Rank #290 · Healthcare
Zhu Yi
Pharmaceuticals · China
Net worth$11.2B
Today−$149M
7 days−$51K
30 days−$172M
Net worth, last 30 days
Low $10.4BHigh $12.0B
Biography
Zhu Yi is the chairman of Biokin Pharmaceutical, a developer of drugs including anesthesia injections, cancer drugs as well as traditional Chinese medicine treatments.
The company went public in Shanghai in 2023, raising $136 million; it has been seeking a Hong Kong IPO since 2024.
Biokin's U.S. subsidiary SystImmune signed in 2023 an $8.4 billion deal with Bristol Myers Squibb to jointly develop and commercialize a potential cancer treatment worldwide.
Zhu taught immunology and microbiology at West China University of Medical Sciences before striking out on his own.
Did you know
Zhu has a master's in biology from Fudan University and a doctorate in management from Sichuan University.
Holdings
| Company | Ticker | Shares | Value |
|---|---|---|---|
| Sichuan Biokin Pharmaceutical | 688506-CN | 299,060,000 | $75.4B |
| Private assets & other | $23M | ||